Skip to main content
Fig. 9 | Cancer Imaging

Fig. 9

From: What scans we will read: imaging instrumentation trends in clinical oncology

Fig. 9

Patient with HCC before and after hadron therapy. DECT helps delineate iodine uptake within the tumour and the recurrent lesions. The contrast accumulations (gray arrows) in the irradiation field (blue arrow) can only be deduced from the iodine map, thus, improving differentiation of HCC and surrounding healthy liver. Data courtesy of the Division of Radiology of the German Cancer Research Center (DKFZ)

Back to article page